Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Evaluate the Safety and Effectiveness of DSC127 in Treating Subjects With Diabetic Ulcers

NCT00796744 is registered in ClinicalTrials.gov with US Biotest, Inc. as lead sponsor.

NCT NCT00796744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00796744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Evaluate the Safety and Effectiveness of DSC127 in Treating Subjects With Diabetic Ulcers
Lead sponsor
US Biotest, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
May 31, 2011
Enrollment
78 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, foot ulcer, diabetic